CHFR and Paclitaxel Sensitivity of Ovarian Cancer

SIMPLE SUMMARY: Studies in tissue culture cell lines have indicated that silencing of the mitotic regulator CHFR is associated with increased paclitaxel sensitivity. More recently, it has been suggested that a UBC13-DNMT1-CHFR pathway also modulates sensitivity of ovarian cancer to paclitaxel in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Wahner Hendrickson, Andrea E., Visscher, Daniel W., Hou, Xiaonan, Goergen, Krista M., Atkinson, Hunter J., Beito, Thomas G., Negron, Vivian, Lingle, Wilma L., Bruzek, Amy K., Hurley, Rachel M., Wagner, Jill M., Flatten, Karen S., Peterson, Kevin L., Schneider, Paula A., Larson, Melissa C., Maurer, Matthew J., Kalli, Kimberly R., Oberg, Ann L., Weroha, S. John, Kaufmann, Scott H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657201/
https://www.ncbi.nlm.nih.gov/pubmed/34885153
http://dx.doi.org/10.3390/cancers13236043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657201/
https://www.ncbi.nlm.nih.gov/pubmed/34885153
http://dx.doi.org/10.3390/cancers13236043

Ejemplares similares